Literature DB >> 17942069

Phex mutation causes overexpression of FGF23 in teeth.

T Onishi1, S Umemura, S Shintani, T Ooshima.   

Abstract

OBJECTIVE: Hyp mice have a disorder in phosphate homeostasis, and display hypo-mineralization in bones and teeth, while the Phex (phosphate regulating gene homologies to endopeptidase on the X chromosome) gene in Hyp mice has a deletion of the 3' end. We investigated whether a mutation of Phex has an effect on the expression level of fibroblast growth factor 23 (FGF23), one of the key factors of phosphate homeostasis, in developing teeth of Hyp mice.
DESIGN: RT-PCR and in situ hybridisation analyses for FGF23 were performed using developing teeth of WT mice. Quantitative RT-PCR analyses for FGF23 were performed using the tooth germs of WT and Hyp mice in both in vivo and in vitro experiments.
RESULTS: Undifferentiated and early secretory ameloblasts as well as odontoblasts expressed FGF23 mRNA during early tooth development. Further, quantitative RT-PCR analyses revealed that the amount of FGF23 mRNA in Hyp mouse teeth was significantly higher than that in wild type mice.
CONCLUSIONS: These findings suggest that loss of Phex function is related to overexpression of FGF23 in teeth, which is an intrinsic defect of Hyp mouse teeth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942069     DOI: 10.1016/j.archoralbio.2007.08.009

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  16 in total

Review 1.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

2.  FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.

Authors:  Kazuyoshi Uchihashi; Teruyo Nakatani; Regina Goetz; Moosa Mohammadi; Xi He; Mohammed S Razzaque
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

Review 3.  The changing face of hypophosphatemic disorders in the FGF-23 era.

Authors:  Janet Y Lee; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

Review 4.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

5.  Expression of fibroblast growth factors (Fgfs) in murine tooth development.

Authors:  Thantrira Porntaveetus; Yoko Otsuka-Tanaka; M Albert Basson; Anne M Moon; Paul T Sharpe; Atsushi Ohazama
Journal:  J Anat       Date:  2011-02-21       Impact factor: 2.610

6.  Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse.

Authors:  H Fong; E Y Chu; K A Tompkins; B L Foster; D Sitara; B Lanske; M J Somerman
Journal:  J Periodontol       Date:  2009-08       Impact factor: 6.993

Review 7.  Fibroblast growth factor 23: state of the field and future directions.

Authors:  Nisan Bhattacharyya; William H Chong; Rachel I Gafni; Michael T Collins
Journal:  Trends Endocrinol Metab       Date:  2012-08-24       Impact factor: 12.015

Review 8.  Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Authors:  Brian L Foster; Kevin A Tompkins; R Bruce Rutherford; Hai Zhang; Emily Y Chu; Hanson Fong; Martha J Somerman
Journal:  Birth Defects Res C Embryo Today       Date:  2008-12

9.  Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets.

Authors:  Giampiero I Baroncelli; Elisa Zampollo; Mario Manca; Benedetta Toschi; Silvano Bertelloni; Angela Michelucci; Alessandro Isola; Alessandra Bulleri; Diego Peroni; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2020-08-08       Impact factor: 2.626

Review 10.  Pharmacological management of X-linked hypophosphataemia.

Authors:  Erik A Imel; Kenneth E White
Journal:  Br J Clin Pharmacol       Date:  2018-10-29       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.